INS and diabetes mellitus: Using NHANES data (2003–2012), Perez et al. (2015) found that Mexican individuals with uncontrolled T2DM, relative to White individuals, were less likely to have regimens intensified to non-insulin triple therapies (7.3% vs 11.3%) or insulin-based therapies (23.7% vs 30.5%) and were more likely to not be on any medications (17.2% vs 10.4%).5 Another potential contributor to worse T2DM outcomes among Hispanic individuals, relative to White individuals, is reduced adherence to diabetes medications.